Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

1 Citation (Scopus)
OriginalsprogEngelsk
Artikelnummerbcr2014204809
TidsskriftB M J Case Reports
Vol/bind2014
Udgave nummerjul23 1
ISSN1757-790X
DOI
StatusUdgivet - 2014

Fingerprint

Epidermal Growth Factor Receptor
Mutation
Therapeutics
Exanthema
Fatigue
Diarrhea
Creatinine
Quality of Life
Erlotinib Hydrochloride
Liver
Enzymes

Citer dette

@article{19330fbaa7ac4f3296b33d017c8b2f15,
title = "Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation",
author = "Szejniuk, {Weronika Maria} and Tine McCulloch and R{\o}e, {Oluf Dimitri}",
note = "2014 BMJ Publishing Group Ltd.",
year = "2014",
doi = "10.1136/bcr-2014-204809",
language = "English",
volume = "2014",
journal = "B M J Case Reports",
issn = "1757-790X",
publisher = "BMJ Group",
number = "jul23 1",

}

Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation. / Szejniuk, Weronika Maria; McCulloch, Tine; Røe, Oluf Dimitri.

I: B M J Case Reports, Bind 2014, Nr. jul23 1, bcr2014204809 , 2014.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation

AU - Szejniuk, Weronika Maria

AU - McCulloch, Tine

AU - Røe, Oluf Dimitri

N1 - 2014 BMJ Publishing Group Ltd.

PY - 2014

Y1 - 2014

U2 - 10.1136/bcr-2014-204809

DO - 10.1136/bcr-2014-204809

M3 - Journal article

VL - 2014

JO - B M J Case Reports

JF - B M J Case Reports

SN - 1757-790X

IS - jul23 1

M1 - bcr2014204809

ER -